Latest Operating Expenses News

Hartshead Resources has submitted a revised development plan for its Anning and Somerville gas fields, featuring a superior export route via CalEnergy's Saturn Banks pipeline. Supported by a strong cash position and committed partners, the company is exploring innovative funding to optimise project economics.

archTIS has reported a standout March quarter with record annual recurring revenue, improved gross margins, and strategic growth through the Direktiv acquisition and new international contracts.

Opthea Limited has discontinued its wet AMD development program following Phase III trial failures, slashing its workforce by 65% amid ongoing financial uncertainty and negotiations with investors.

Novatti Group Limited has achieved a key turnaround milestone by reporting positive cash EBITDA of $100k in Q3 FY25, alongside record quarterly revenue of $13.4 million and improved margins in its core Payments AU/NZ business.

BirdDog Technology reported a slight 4.1% decline in Q3 FY25 sales to A$3.6 million while progressing strongly on its next-generation product roadmap and implementing significant cost reductions.

PainChek Limited reports strong progress toward FDA De Novo clearance for US market entry, launches its Infant App in Australia, and achieves robust global licence growth with a 30% year-on-year revenue increase.

WhiteHawk Limited reported solid Q1 2025 progress with a $2.4 million contract renewal and a landmark $920 million subcontract on a U.S. federal government vehicle, alongside multiple new cyber risk program wins.

Harris Technology Group reported steady Q3 FY25 sales of $3.3 million alongside a modest operating cash outflow, while successfully raising $1.5 million to fuel expansion in refurbished electronics.

Lincoln Minerals has launched a comprehensive re-assay program targeting historic drill core at its Minbrie Cu-Pb-Zn Project, alongside progressing graphite downstream test work and advancing its Green Iron Magnetite Project with strong industry interest.

Zelira Therapeutics has enhanced its financial flexibility through a $1.15 million R&D tax refund and a $1 million At-the-Market equity facility, while progressing FDA trial preparations for its HOPE® 1 autism treatment.

Aeris Environmental Ltd posted solid March quarter results, driven by its AerisTech joint venture’s initial hardware and software sales and expanding consumables segment. The company is leveraging new sustainability regulations to position its smart building ecosystem for growth.

4DMedical Limited reports a 103% surge in year-to-date revenue, secures major contracts with leading healthcare providers, and advances its CT:VQ™ technology towards FDA clearance.